Controlled Remote Monitoring and Optimization of Oxygen Therapy in Preterm Infants

NCT07161908 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2025-09-09

No results posted yet for this study

Summary

The project is a national, prospective, multicenter, interventional pilot project focused on controlled remote monitoring and optimization of oxygen therapy for premature infants in the Czech Republic. The primary aim of the project is to prepare, test, and develop a proposal for a national methodology for the care of preterm newborns. This will reduce health risks in premature infants and minimize the negative impacts on the overall development of the child and the family of the premature infant.

Conditions

  • BPD - Bronchopulmonary Dysplasia
  • Pulmonary Hypertension

Interventions

DEVICE

Pulse oximeter

To ensure proper treatment, the infant will be continuously monitored with a pulse oximeter. Based on oxygen saturation levels, the treatment may be adjusted according to pre-established protocols. It is required that the saturation stays above a certain value for more than 95 % of the 12-hour measurement period. If the defined saturation values are reached, the parents will reduce the oxygen flow by one degree for 20 minutes in the hospital/home setting (20 minute test) and if the saturation values remain at 93 % or more during this period, overnight 12 hour monitoring will also be performed to confirm stable saturation values of 93 % or more for 95 % or more of the monitoring time. Thanks to modern specialized pulse oximeters, it is possible to ensure accurate, long-term, remotely managed monitoring of the infant and to interactively optimize oxygen therapy based on current oxygen saturation levels.

Sponsors & Collaborators

  • České Budějovice Hospital

    collaborator OTHER
  • University Hospital Olomouc

    collaborator OTHER
  • Institute for the Care of Mother and Child, Prague, Czech Republic

    collaborator OTHER
  • General University Hospital, Prague

    collaborator OTHER
  • Institute of Health Information and Statistics of the Czech Republic

    lead OTHER_GOV

Principal Investigators

  • Richard Plavka, prof. · General Hospital University in Prague

  • Jana Tuková, Ph.D. · General Hospital University in Prague

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
36 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-25
Primary Completion
2026-11-30
Completion
2027-02-28

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07161908 on ClinicalTrials.gov